Umezawamides, new bioactive polycyclic tetramate macrolactams isolated from a combined-culture of Umezawaea sp. and mycolic acid-containing bacterium

J Antibiot (Tokyo). 2018 Jul;71(7):653-657. doi: 10.1038/s41429-018-0040-4. Epub 2018 Mar 14.

Abstract

New polycyclic tetramate macrolactams, Umezawamides A (1) and B (2) were isolated from a combined-culture of Umezawaea sp. RD066910 and mycolic-acid containing bacterium Tsukamurella pulmonis TP-B0596. Their planar structures and partial stereochemistries were determined based on the spectroscopic analysis, MMFF conformational search, and ECD calculations. Umezawamides are the first secondary metabolites isolated from the genus Umezawaea and they exhibited cytotoxicities to P388 murine leukemia cells. Furthermore, umezawamide A (1) showed growth inhibitory activity against Candida albicans.

MeSH terms

  • Actinomycetales / chemistry*
  • Animals
  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / isolation & purification*
  • Anti-Bacterial Agents / pharmacology
  • Antibiotics, Antineoplastic / chemistry
  • Antibiotics, Antineoplastic / isolation & purification
  • Antibiotics, Antineoplastic / pharmacology
  • Antifungal Agents / chemistry
  • Antifungal Agents / isolation & purification
  • Antifungal Agents / pharmacology
  • Bacteria / drug effects
  • Candida albicans / drug effects
  • Cell Line, Tumor
  • Humans
  • Lactams, Macrocyclic / isolation & purification*
  • Lactams, Macrocyclic / pharmacology*
  • Leukemia P388 / drug therapy
  • Mice
  • Microbial Sensitivity Tests
  • Molecular Conformation
  • Mycolic Acids / metabolism*
  • Polycyclic Compounds / isolation & purification*
  • Polycyclic Compounds / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Antibiotics, Antineoplastic
  • Antifungal Agents
  • Lactams, Macrocyclic
  • Mycolic Acids
  • Polycyclic Compounds